Advertisement

Topics

Emulate and AstraZeneca announce Organs-on-Chips partnership

06:13 EDT 21 May 2018 | Net Resources International

AstraZeneca has announced a collaboration with Emulate to develop and embed the start-up’s Organs-on-Chips technology within its Innovative Medicines and...
Read More...

The post Emulate and AstraZeneca announce Organs-on-Chips partnership appeared first on Drug Development Technology.

Original Article: Emulate and AstraZeneca announce Organs-on-Chips partnership

NEXT ARTICLE

More From BioPortfolio on "Emulate and AstraZeneca announce Organs-on-Chips partnership"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...